Mounjaro
Every GLP-1 the FDA has approved, and the active ingredient inside each one.
What is Mounjaro?
Tirzepatide sold as a weekly injection for type 2 diabetes, approved 2022.
Identical molecule to Zepbound with a different label, and it carries the same four-week backup-contraception warning for anyone on oral hormonal contraceptives.
Mounjaro/Zepbound + birth control →
GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature.
Where Mounjaro comes up on this site
On GLP Watchdog, Mounjaro comes up in 6 research articles, 43 seller reviews, 8 FDA warning letters and 4 tools. Browse the FDA warning letters.
Research that discusses it
- Is There a Tirzepatide Pill? What Sellers Ship
- Stomach Pain on a GLP-1: What Is Expected and What Is a Warning Sign
- Why a GLP-1 Raises Your Heart Rate, and When Palpitations Matter
- Tirzepatide Week by Week: What the SURMOUNT Trials Recorded
- Is Zepbound a Semaglutide? Brand Names vs Molecules
- GLP-1s and Hormonal Birth Control: Which Labels Carry the Warning
Drug pages
Tools that use it
Seller reviews that mention it
Other terms under Drugs and brands
Where the evidence lives
- Mounjaro/Zepbound + birth control
- The full GLP-1 glossary (149 terms, 8 categories)
- Research articles — written from primary sources
- Tools and calculators
- Compare GLP-1 telehealth providers